Hematology
Ibiayi Dagogo-Jack, M.D.
Associate Professor of Medicine, Harvard Medical School; Director of Molecular Testing Integration, Mesothelioma Program Leader, Massachusetts General Hospital
Dr. Ibiayi Dagogo-Jack is a thoracic medical oncologist at Massachusetts General Hospital Cancer Center in Boston, MA, specializing in lung cancer, mesothelioma, and other thoracic malignancies. She leads the mesothelioma program and serves as Director of Molecular Testing Integration, focusing on precision oncology approaches. Her clinical practice emphasizes targeted therapies, immunotherapies, and novel drug combinations for patients with non-small cell lung carcinoma, pleural and peritoneal
19+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- University of Chicago Pritzker School of Medicine — M.D., 2011
- Brigham and Women's Hospital — Residency, Internal Medicine
- Dana-Farber Cancer Institute / Massachusetts General Hospital — Fellowship, Hematology/Oncology
Peer Recognition
- Alpha Omega Alpha — Inductee
2011
- American Society of Clinical Oncology — Fellow Award
2025
- GRACE — Patient Educator of the Year
2022
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Massachusetts General Hospital
- North Shore Medical Center
- Mass General Brigham Cancer Institute
- Massachusetts General Hospital, Boston, MA
Languages
English
Experience
19+ years in practice